Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- Martek Releases Preliminary Results of Cardiovascular Study
Study found that after 13 weeks, the group taking 1g of DHA per day had significantly lower triglyceride levels than the placebo group, and at 26 weeks, the same group had significantly lower triglyceride levels compared to baseline, but the reduction was not statistically significant compared to the placebo group, (which was the study's primary endpoint).
- Martek Releases Preliminary Results of Cardiovascular Study
Study found that after 13 weeks, the group taking 1g of DHA per day had significantly lower triglyceride levels than the placebo group, and at 26 weeks, the same group had significantly lower triglyceride levels compared to baseline, but the reduction was not statistically significant compared to the placebo group, (which was the study's primary endpoint).
- Martek Releases Preliminary Results of Cardiovascular Study
Study found that after 13 weeks, the group taking 1g of DHA per day had significantly lower triglyceride levels than the placebo group, and at 26 weeks, the same group had significantly lower triglyceride levels compared to baseline, but the reduction was not statistically significant compared to the placebo group, (which was the study's primary endpoint).
- Martek Releases Preliminary Results of Cardiovascular Study
Study found that after 13 weeks, the group taking 1g of DHA per day had significantly lower triglyceride levels than the placebo group, and at 26 weeks, the same group had significantly lower triglyceride levels compared to baseline, but the reduction was not statistically significant compared to the placebo group, (which was the study's primary endpoint).
- Martek Releases Preliminary Results of Cardiovascular Study
Study found that after 13 weeks, the group taking 1g of DHA per day had significantly lower triglyceride levels than the placebo group, and at 26 weeks, the same group had significantly lower triglyceride levels compared to baseline, but the reduction was not statistically significant compared to the placebo group, (which was the study's primary endpoint).
- Largest Trial of Vitamin E Shows Heart Health Benefit For Women
results of a new study involving nearly 40,000 healthy women finds that vitamin E significantly reduced the risk of death from cardiovascular disease; study, published in the July 6 edition of the Journal of the American Medical Association, also confirmed that vitamin E is safe.
- Largest Trial of Vitamin E Shows Heart Health Benefit For Women
results of a new study involving nearly 40,000 healthy women finds that vitamin E significantly reduced the risk of death from cardiovascular disease; study, published in the July 6 edition of the Journal of the American Medical Association, also confirmed that vitamin E is safe.
- Largest Trial of Vitamin E Shows Heart Health Benefit For Women
results of a new study involving nearly 40,000 healthy women finds that vitamin E significantly reduced the risk of death from cardiovascular disease; study, published in the July 6 edition of the Journal of the American Medical Association, also confirmed that vitamin E is safe.
- Largest Trial of Vitamin E Shows Heart Health Benefit For Women
results of a new study involving nearly 40,000 healthy women finds that vitamin E significantly reduced the risk of death from cardiovascular disease; study, published in the July 6 edition of the Journal of the American Medical Association, also confirmed that vitamin E is safe.
- Largest Trial of Vitamin E Shows Heart Health Benefit For Women
results of a new study involving nearly 40,000 healthy women finds that vitamin E significantly reduced the risk of death from cardiovascular disease; study, published in the July 6 edition of the Journal of the American Medical Association, also confirmed that vitamin E is safe.
- Largest Trial of Vitamin E Shows Heart Health Benefit For Women
results of a new study involving nearly 40,000 healthy women finds that vitamin E significantly reduced the risk of death from cardiovascular disease; study, published in the July 6 edition of the Journal of the American Medical Association, also confirmed that vitamin E is safe.
- Study Shows Vitamin E has Heart Health Benefit for Women
A long term Vitamin E study on healthy women, reported in the July 6 issue of the Journal of the American Medical Association, (JAMA) indicates that not only is Vitamin E safe, it significantly reduced the risk of death from major cardiovascular events (heart attack, stroke) by 24% and those over 65 years old experienced an even greater benefit.
- Study Indicates That Tocotrienol Is More Effective Than a-Tocopherol In Reducing Expression of Adhesion Molecules
Study indicates that tocotrienols were a more effective form of vitamin E in reducing endothelial expression of adhesion molecules in the blood vasculature, relative to the effects of α-tocopherol.
- Study Indicates That Tocotrienol Is More Effective Than a-Tocopherol In Reducing Expression of Adhesion Molecules
Study indicates that tocotrienols were a more effective form of vitamin E in reducing endothelial expression of adhesion molecules in the blood vasculature, relative to the effects of α-tocopherol.
- Study Indicates That Tocotrienol Is More Effective Than a-Tocopherol In Reducing Expression of Adhesion Molecules
Study indicates that tocotrienols were a more effective form of vitamin E in reducing endothelial expression of adhesion molecules in the blood vasculature, relative to the effects of α-tocopherol.
- Study Indicates That Tocotrienol Is More Effective Than a-Tocopherol In Reducing Expression of Adhesion Molecules
Study indicates that tocotrienols were a more effective form of vitamin E in reducing endothelial expression of adhesion molecules in the blood vasculature, relative to the effects of α-tocopherol.
- Study Indicates That Tocotrienol Is More Effective Than a-Tocopherol In Reducing Expression of Adhesion Molecules
Study indicates that tocotrienols were a more effective form of vitamin E in reducing endothelial expression of adhesion molecules in the blood vasculature, relative to the effects of α-tocopherol.
- Yale Study Reaffirms Link Between Dark Chocolate and Cardiovascular Benefits
The study used ultrasound technology and sophisticated measurements to assess the effects of eating high-cacao content dark chocolate, Hershey's(R) Extra Dark, on the arterial function of 45 moderately overweight adults, and measured subjects' blood pressure before and two hours after eating two servings (74 grams) of dark chocolate, demonstrating improvements in blood pressure, as well as the ability of blood vessels to dilate and increase flow.
- Zila Cites Second Study Linking Ester-E(R) To Healthy Cardiovascular Function
In this animal study, Ester-E(R) significantly reduced LDL-C (so-called bad cholesterol), triglycerides, and plaque formation, while regular vitamin E had no significant effect.
- Zila Cites Second Study Linking Ester-E(R) To Healthy Cardiovascular Function
In this animal study, Ester-E(R) significantly reduced LDL-C (so-called bad cholesterol), triglycerides, and plaque formation, while regular vitamin E had no significant effect.
- Zila Cites Second Study Linking Ester-E(R) To Healthy Cardiovascular Function
In this animal study, Ester-E(R) significantly reduced LDL-C (so-called bad cholesterol), triglycerides, and plaque formation, while regular vitamin E had no significant effect.
- Zila Cites Second Study Linking Ester-E(R) To Healthy Cardiovascular Function
In this animal study, Ester-E(R) significantly reduced LDL-C (so-called bad cholesterol), triglycerides, and plaque formation, while regular vitamin E had no significant effect.
- Zila Cites Second Study Linking Ester-E(R) To Healthy Cardiovascular Function
In this animal study, Ester-E(R) significantly reduced LDL-C (so-called bad cholesterol), triglycerides, and plaque formation, while regular vitamin E had no significant effect.
- Effects of Red Wine Consumption on Risk Factors for Coronary Heart Disease
- Study: Chromium Picolinate May Provide Cardiovascular Benefits in Pre-Diabetes
Preclinical study on rats, conducted at the University of Alberta, and presented at the 3rd World Congress on Insulin Resistance Syndrome, shows daily use of chromium picolinate provides significant cardiovascular benefits in pre-diabetic rats that have insulin resistance
- Study: Chromium Picolinate May Provide Cardiovascular Benefits in Pre-Diabetes
Preclinical study on rats, conducted at the University of Alberta, and presented at the 3rd World Congress on Insulin Resistance Syndrome, shows daily use of chromium picolinate provides significant cardiovascular benefits in pre-diabetic rats that have insulin resistance
- Study: Chromium Picolinate May Provide Cardiovascular Benefits in Pre-Diabetes
Preclinical study on rats, conducted at the University of Alberta, and presented at the 3rd World Congress on Insulin Resistance Syndrome, shows daily use of chromium picolinate provides significant cardiovascular benefits in pre-diabetic rats that have insulin resistance
- Study: Chromium Picolinate May Provide Cardiovascular Benefits in Pre-Diabetes
Preclinical study on rats, conducted at the University of Alberta, and presented at the 3rd World Congress on Insulin Resistance Syndrome, shows daily use of chromium picolinate provides significant cardiovascular benefits in pre-diabetic rats that have insulin resistance
- Study: Chromium Picolinate May Provide Cardiovascular Benefits in Pre-Diabetes
Preclinical study on rats, conducted at the University of Alberta, and presented at the 3rd World Congress on Insulin Resistance Syndrome, shows daily use of chromium picolinate provides significant cardiovascular benefits in pre-diabetic rats that have insulin resistance
- Study: Chromium Picolinate May Provide Cardiovascular Benefits in Pre-Diabetes
Preclinical study on rats, conducted at the University of Alberta, and presented at the 3rd World Congress on Insulin Resistance Syndrome, shows daily use of chromium picolinate provides significant cardiovascular benefits in pre-diabetic rats that have insulin resistance
- Nutrient Supplementation Reduces Irregular Heartbeat (Arrhythmia) in Patients
A randomized, double-blind, placebo-controlled, multi-center study, published in the November 2005 issue of JANA, indicates that nutrient supplementation led to a statistically significant decrease in the frequency of clinically apparent arrhythmic episodes, with further improvement in frequency over time.
- Nutrient Supplementation Reduces Irregular Heartbeat (Arrhythmia) in Patients
A randomized, double-blind, placebo-controlled, multi-center study, published in the November 2005 issue of JANA, indicates that nutrient supplementation led to a statistically significant decrease in the frequency of clinically apparent arrhythmic episodes, with further improvement in frequency over time.
- Nutrient Supplementation Reduces Irregular Heartbeat (Arrhythmia) in Patients
A randomized, double-blind, placebo-controlled, multi-center study, published in the November 2005 issue of JANA, indicates that nutrient supplementation led to a statistically significant decrease in the frequency of clinically apparent arrhythmic episodes, with further improvement in frequency over time.
- Nutrient Supplementation Reduces Irregular Heartbeat (Arrhythmia) in Patients
A randomized, double-blind, placebo-controlled, multi-center study, published in the November 2005 issue of JANA, indicates that nutrient supplementation led to a statistically significant decrease in the frequency of clinically apparent arrhythmic episodes, with further improvement in frequency over time.
- Nutrient Supplementation Reduces Irregular Heartbeat (Arrhythmia) in Patients
A randomized, double-blind, placebo-controlled, multi-center study, published in the November 2005 issue of JANA, indicates that nutrient supplementation led to a statistically significant decrease in the frequency of clinically apparent arrhythmic episodes, with further improvement in frequency over time.
- Study Indicates B Vitamins not Cardioprotective
- Study Indicates B Vitamins not Cardioprotective
- Study Indicates B Vitamins not Cardioprotective
- Study Indicates B Vitamins not Cardioprotective
- Study Indicates B Vitamins not Cardioprotective
- Study: Fish Oils Plus Statins Help Protect Heart
- Study: Fish Oils Plus Statins Help Protect Heart
- Study: Fish Oils Plus Statins Help Protect Heart
- Study: Fish Oils Plus Statins Help Protect Heart
- Study: Fish Oils Plus Statins Help Protect Heart
- Fish Oil Supplements Prevent Declines in Heart Rate Variability
- Fish Oil Supplements Prevent Declines in Heart Rate Variability
- Fish Oil Supplements Prevent Declines in Heart Rate Variability
- Fish Oil Supplements Prevent Declines in Heart Rate Variability
- Fish Oil Supplements Prevent Declines in Heart Rate Variability
- Study: Effect of Soy Diet on Mice with Hypertrophic Cardiomyopathy
- Study: Effect of Soy Diet on Mice with Hypertrophic Cardiomyopathy
- Study: Effect of Soy Diet on Mice with Hypertrophic Cardiomyopathy
- Study: Effect of Soy Diet on Mice with Hypertrophic Cardiomyopathy
- Study: Effect of Soy Diet on Mice with Hypertrophic Cardiomyopathy
- Tomato Extract May Help Lower Blood Pressure
- Tomato Extract May Help Lower Blood Pressure
- Tomato Extract May Help Lower Blood Pressure
- Tomato Extract May Help Lower Blood Pressure
- Tomato Extract May Help Lower Blood Pressure
- Study Indicates That Lyc-O-Mato® Reduces Blood Pressure
Randomized double blind, placebo controlled crossover trial, conducted at Ben-Gurion University, Israel, indicated that a daily intake of tomato extract Lyc-O-Mato® in soft gel capsules was associated with a significant drop in both systolic and diastolic blood pressure after eight weeks of supplementation of a normal diet.
- Study Indicates That Lyc-O-Mato® Reduces Blood Pressure
Randomized double blind, placebo controlled crossover trial, conducted at Ben-Gurion University, Israel, indicated that a daily intake of tomato extract Lyc-O-Mato® in soft gel capsules was associated with a significant drop in both systolic and diastolic blood pressure after eight weeks of supplementation of a normal diet.
- Study Indicates That Lyc-O-Mato® Reduces Blood Pressure
Randomized double blind, placebo controlled crossover trial, conducted at Ben-Gurion University, Israel, indicated that a daily intake of tomato extract Lyc-O-Mato® in soft gel capsules was associated with a significant drop in both systolic and diastolic blood pressure after eight weeks of supplementation of a normal diet.
- Study Indicates That Lyc-O-Mato® Reduces Blood Pressure
Randomized double blind, placebo controlled crossover trial, conducted at Ben-Gurion University, Israel, indicated that a daily intake of tomato extract Lyc-O-Mato® in soft gel capsules was associated with a significant drop in both systolic and diastolic blood pressure after eight weeks of supplementation of a normal diet.
- Study Indicates That Lyc-O-Mato® Reduces Blood Pressure
Randomized double blind, placebo controlled crossover trial, conducted at Ben-Gurion University, Israel, indicated that a daily intake of tomato extract Lyc-O-Mato® in soft gel capsules was associated with a significant drop in both systolic and diastolic blood pressure after eight weeks of supplementation of a normal diet.
- Dr. Navindra Seeram to speak on pomegranate bioavailability at Supplyside West
Dr. Navindra Seeram, Assistant Director of the University of California Los Angeles (UCLA) Center for Human Nutrition, will present “Are Polyphenols from Pomegranates, Strawberries and Tea Bioavailable in Human and Animal Blood and Tissues?” on Friday, November 11, at 10 am during the Educational Sessions of Supplyside West, Las Vegas.
- Dr. Navindra Seeram to speak on pomegranate bioavailability at Supplyside West
Dr. Navindra Seeram, Assistant Director of the University of California Los Angeles (UCLA) Center for Human Nutrition, will present “Are Polyphenols from Pomegranates, Strawberries and Tea Bioavailable in Human and Animal Blood and Tissues?” on Friday, November 11, at 10 am during the Educational Sessions of Supplyside West, Las Vegas.
- Study Suggests Metagenics' FirstLine Therapy Lifestyle Program Better Than AHA Diet to Reduce Cardiovascular Disease Risks in Postmenopausal Women
February issue of the journal Nutrition (Vol. 22(2), pp. 104-113) features the results of a 2-arm prospective clinical trial in postmenopausal women at risk for cardiovascular disease (CVD), suggesting that patients exhibited a greater improvement in established cardiovascular health markers when comparing Metagenics' FirstLine Therapy(R) therapeutic lifestyle program (FLT) -- to a standard American Heart Association dietary plan (AHAD) and exercise.
- Study Suggests Metagenics' FirstLine Therapy Lifestyle Program Better Than AHA Diet to Reduce Cardiovascular Disease Risks in Postmenopausal Women
February issue of the journal Nutrition (Vol. 22(2), pp. 104-113) features the results of a 2-arm prospective clinical trial in postmenopausal women at risk for cardiovascular disease (CVD), suggesting that patients exhibited a greater improvement in established cardiovascular health markers when comparing Metagenics' FirstLine Therapy(R) therapeutic lifestyle program (FLT) -- to a standard American Heart Association dietary plan (AHAD) and exercise.
- Study Suggests Metagenics' FirstLine Therapy Lifestyle Program Better Than AHA Diet to Reduce Cardiovascular Disease Risks in Postmenopausal Women
February issue of the journal Nutrition (Vol. 22(2), pp. 104-113) features the results of a 2-arm prospective clinical trial in postmenopausal women at risk for cardiovascular disease (CVD), suggesting that patients exhibited a greater improvement in established cardiovascular health markers when comparing Metagenics' FirstLine Therapy(R) therapeutic lifestyle program (FLT) -- to a standard American Heart Association dietary plan (AHAD) and exercise.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Another Reason to Choose Healthy Lifestyle Habits
- Another Reason to Choose Healthy Lifestyle Habits
|
HACKETTSTOWN, N.J., Jan 17, 2006 /PRNewswire via COMTEX/ -- While a growing number of studies has shown a link between flavanol-rich cocoa and cardiovascular health, scientists have now substantiated a causal relationship between specific compounds present in cocoa and cardiovascular health. Published today in the Proceedings of the National Academy of Sciences of the United States of America (PNAS)(1), this new study identifies the flavanol, (-)epicatechin, as one of the bioactive nutrients in cocoa that can improve the ability of blood vessels to relax.
An international team of scientists from the University of Dusseldorf, Germany; the University of California, Davis; Mars, Incorporated; and Harvard Medical School conducted a series of studies examining the role of specific cocoa flavanols in cardiovascular health.
"Applying accepted causality criteria and gold standard methodologies, we have been able to advance our understanding of the relationship between the intake of certain flavanols present in cocoa, their absorption into the circulation, and their effects on cardiovascular function," said lead author Hagen Schroeter, PhD, faculty member at the University of California, Davis. "This study established direct evidence for the effect of the flavanol (-)epicatechin as a mediator of blood vessel relaxation."
In a randomized, double-blind, cross-over investigation, the researchers provided healthy male participants with a specially prepared cocoa drink that was either high or low in certain cocoa flavanols. Only the group consuming the flavanol-rich cocoa experienced increased blood vessel relaxation. The researchers demonstrated that the relaxation response mediated by cocoa flavanols is dependent on nitric oxide, a key signal released by the inner lining of blood vessels (the endothelium) essential for normal blood vessel function and healthy blood flow.
To provide direct evidence for the specific flavanol in cocoa that is partly responsible for the circulatory benefits, the research team conducted a "proof-of-concept" study. During this part of the investigation, participants drank either a placebo or a beverage containing isolated, cocoa-derived (-)epicatechin. The researchers demonstrated that the group of participants receiving the (-)epicatechin had vessel relaxation and nitric oxide responses similar to those experienced following the consumption of the flavanol-rich cocoa drink. Based on these findings, the investigators concluded that (-)epicatechin is one of the active nutrients in certain cocoas exerting the observed vascular benefits.
"Pinpointing specific nutrients responsible for the observed cardiovascular effects, as we are seeing here with (-)epicatechin, opens up new possibilities for the development of dietary or therapeutic interventions for cardiovascular disease," said co-author Norman Hollenberg, MD, PhD, professor of medicine at Harvard Medical School.
(-)Epicatechin, a nutrient that may be found in certain fruit and vegetables, green teas, red wine and purple grape juice, is especially abundant in certain cocoas. "This new insight into the bioactivity of flavanol nutrients is an important piece of information that will help us understand why diets rich in fruits and vegetables promote cardiovascular health," said co-author Carl L. Keen, PhD, professor of nutrition and internal medicine at the University of California, Davis.
To assess the potential long-term benefits of a flavanol-rich diet, the researchers studied two populations of Kuna Indians of Panama. Previous work by Dr. Norman Hollenberg has shown that hypertension is rare among the indigenous Kuna Indians living on the islands as compared to those living on the mainland. The island-dwelling Kuna Indians traditionally consume large quantities of flavanol-rich cocoa (an average of 3-4 cups daily), while those who live in the suburbs of Panama City consume very little cocoa, supporting the idea that cocoa flavanols may be responsible for the lower blood pressure in the island dwellers. Linking Dr. Hollenberg's observations to their own findings, Schroeter and colleagues found that the Kuna Indians on the island who regularly consume flavanol-rich cocoa had higher levels of flavanols, as well as higher levels of nitric oxide metabolites in their circulation compared to the mainland Indians who consume little cocoa.
"These findings suggest that frequent intake of cocoa flavanols can have biological effects with important implications for long-term cardiovascular health," said Dr. Hollenberg.
In addition to collaborating on this research, Mars, Incorporated financially supported it and provided the flavanol-rich cocoa (Cocoapro(R) cocoa powder) that was used throughout these investigations.
"After more than 15 years of commitment to cocoa science research, we are excited to see such great progress in uncovering the link between cocoa flavanols and heart health," said Harold Schmitz, PhD, chief science officer of Mars, Incorporated and co-author of the study. "Traditional cocoa processing often destroys the flavanols, but Mars technology helps to retain these naturally occurring nutrients from cocoa. This new research emphasizes the importance of understanding the potential public health applications of emerging cocoa science, which is a challenge we take very seriously at Mars."
Cocoapro(R) cocoa powder is used in Dove(R) Dark Chocolate, as well as in the new heart-healthy snack CocoaVia(TM).
For more information on the science of flavanols, visit http://www.cocoapro.com or http://www.cocoavia.com.
Mars, Incorporated is one of the world's top producers of chocolate, and with a strong commitment to health research, is the leader in the science of cocoa, chocolate and health. Mars uses patented and proprietary methods of processing cocoa beans to retain as much of their naturally occurring flavanols as possible, marking these products with the Cocoapro(R) seal, a hand holding a cocoa bean to signify the careful handling. For more information please visit http://www.chocolateinfo.com or http://www.cocoapro.com.
Mars Nutrition for Health & Well-Being, a new division of Mars North America, will develop and launch new foods, snacks, beverages and lifestyle support to better serve the nutritional and well-being needs of the consumer. The mission of the division is to be a trusted partner in healthy lifestyles, enabling consumers to look, perform and feel their best every day. Mars Nutrition for Health & Well-Being, launched in June 2004, is based in Hackettstown, NJ.
(1) Schroeter H, Heiss C, Balzer J, Kleinbongard P, Keen CL, Hollenberg NK, Sies H, Kwik-Uribe C., Schmitz HH, Kelm M. (-)Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans. Proceedings of the National Academy of Sciences of the United States of America. 2006; 108:1024-1029. Online publication: www.pnas.org/papbyrecent.shtml |